These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 28785448

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Metabolic therapy of heart failure.
    Fragasso G, Salerno A, Spoladore R, Bassanelli G, Arioli F, Margonato A.
    Curr Pharm Des; 2008; 14(25):2582-91. PubMed ID: 18991675
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Trimetazidine Ameliorates Myocardial Metabolic Remodeling in Isoproterenol-Induced Rats Through Regulating Ketone Body Metabolism via Activating AMPK and PPAR α.
    Li H, Ma Z, Zhai Y, Lv C, Yuan P, Zhu F, Wei L, Li Q, Qi X.
    Front Pharmacol; 2020; 11():1255. PubMed ID: 32922293
    [Abstract] [Full Text] [Related]

  • 6. Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets.
    Fukushima A, Milner K, Gupta A, Lopaschuk GD.
    Curr Pharm Des; 2015; 21(25):3654-64. PubMed ID: 26166604
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Modulation of fatty acids oxidation in heart failure by selective pharmacological inhibition of 3-ketoacyl coenzyme-A thiolase.
    Fragasso G, Spoladore R, Cuko A, Palloshi A.
    Curr Clin Pharmacol; 2007 Sep; 2(3):190-6. PubMed ID: 18690865
    [Abstract] [Full Text] [Related]

  • 13. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.
    Zhang L, Jaswal JS, Ussher JR, Sankaralingam S, Wagg C, Zaugg M, Lopaschuk GD.
    Circ Heart Fail; 2013 Sep 01; 6(5):1039-48. PubMed ID: 23861485
    [Abstract] [Full Text] [Related]

  • 14. Metabolic therapy for the diabetic patients with ischaemic heart disease.
    Rosano GM, Vitale C, Volterrani M, Fini M.
    Coron Artery Dis; 2005 Nov 01; 16 Suppl 1():S17-21. PubMed ID: 16340399
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency.
    Ho KL, Zhang L, Wagg C, Al Batran R, Gopal K, Levasseur J, Leone T, Dyck JRB, Ussher JR, Muoio DM, Kelly DP, Lopaschuk GD.
    Cardiovasc Res; 2019 Sep 01; 115(11):1606-1616. PubMed ID: 30778524
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure.
    Mori J, Zhang L, Oudit GY, Lopaschuk GD.
    J Mol Cell Cardiol; 2013 Oct 01; 63():98-106. PubMed ID: 23886814
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.